Literature DB >> 12494283

Sexual disabilities are not singularities.

K Fugl-Meyer1, A R Fugl-Meyer.   

Abstract

This report is based on a survey (performed 1996) of sex life in a nationally representative sample of Swedish women (n=1335) and men (n=1475) aged 18-74 y. From that survey we have previously reported on prevalence of sexual disabilities and problems caused by them (1). The main object of this article is to describe intra- and inter-gender concurrence of sexual disabilities and problems in sexually active subjects. Furthermore, the relative risk of low level of sexual well-being as predicted by sexual disabilities and distress is addressed. Respondents (59% of target sample) participated in an investigation which combined structured interviews with questionnaires/checklists. Main results are that within and across genders sexual disabilities concur to significant degrees. Of the women 48 and 26% reported at least one own and partner sexual disability or distress caused by them, respectively. For the men the corresponding proportions were 26 and 17%, respectively. Odds ratios showed that for the women low sexual interest, difficulties in obtaining orgasm and partner's early ejaculation were significant predictors of low level of sexual well-being. For the men low level of interest and partner's difficulties in obtaining orgasm were the only, but equally powerful, predictors. It is concluded that in clinical practice and for those who have a partner, sexual disabilities and distress caused by them should be regarded from the partner relationship perspective.

Entities:  

Mesh:

Year:  2002        PMID: 12494283     DOI: 10.1038/sj.ijir.3900914

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  22 in total

Review 1.  Advances in understanding and treating premature ejaculation.

Authors:  Theodore R Saitz; Ege Can Serefoglu
Journal:  Nat Rev Urol       Date:  2015-10-27       Impact factor: 14.432

2.  Evaluation of the quality of life of patients with premature ejaculation (lifelong and acquired).

Authors:  Bahadır Ermeç; Uğur Yucetas; Haydar Güler; Mehmet Gokhan Culha; Mustafa Kadıhasanoğlu
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

Review 3.  New insights on premature ejaculation: a review of definition, classification, prevalence and treatment.

Authors:  Ege C Serefoglu; Theodore R Saitz
Journal:  Asian J Androl       Date:  2012-10-15       Impact factor: 3.285

4.  Frequency of etiological factors among patients with acquired premature ejaculation: prospective, observational, single-center study.

Authors:  Mehmet Gokhan Culha; Murat Tuken; Serkan Gonultas; Omer Onur Cakir; Ege Can Serefoglu
Journal:  Int J Impot Res       Date:  2019-09-03       Impact factor: 2.896

5.  Prevalence of erectile and ejaculatory difficulties among men in Croatia.

Authors:  Aleksandar Stulhofer; Zarko Bajić
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

6.  How Serious Is Erectile Dysfunction in Men's Lives? Comparative Data From Korean Adults.

Authors:  Yoon Seob Ji; Ji Woong Choi; Young Hwii Ko; Phil Hyun Song; Hee Chang Jung; Ki Hak Moon
Journal:  Korean J Urol       Date:  2013-07-15

Review 7.  Late-stage clinical development in lower urogenital targets: sexual dysfunction.

Authors:  Usman Azam
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

8.  Sexual dysfunction and spousal communication in couples coping with prostate cancer.

Authors:  Hoda Badr; Cindy L Carmack Taylor
Journal:  Psychooncology       Date:  2009-07       Impact factor: 3.894

9.  Research into the efficacy and cost-effectiveness of brief, free of charge and anonymous sex counselling to improve (mental) health in youth: design of a randomised controlled trial.

Authors:  Andrea Grauvogl; Silvia M A A Evers; Katy van den Hoek; Evert van der Veen; Anja Franke; Jacques J D M van Lankveld
Journal:  BMC Public Health       Date:  2009-12-13       Impact factor: 3.295

Review 10.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.